Trial Profile
An open, self-control and multiple-center study to evaluate safety and efficacy of Protopic (0.1% tacrolimus) for vitiliginous patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Apr 2016
Price :
$35
*
At a glance
- Drugs Tacrolimus (Primary)
- Indications Vitiligo
- Focus Therapeutic Use
- 25 Jul 2014 New trial record